Bausch Health Companies (BHC) Non-Current Assets (2009 - 2026)

Bausch Health Companies (BHC) reported Non-Current Assets of $18.5 billion for Q1 2026, down 10.48% on a YoY basis from $20.7 billion in Q1 2025, and down 8.36% sequentially from $20.2 billion in Q4 2025.

Bausch Health Companies (BHC) Non-Current Assets (2009 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 18 years of Non-Current Assets data on file, last reported at $18.5 billion in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 10.48% year-over-year to $18.5 billion; the trailing twelve-month figure through Mar 2026 stood at $80.1 billion (down 4.59% YoY), and the FY2025 full-year result was $20.2 billion, down 2.6% from the prior year.
  • Non-Current Assets slipped to $18.5 billion in Q1 2026, from $20.2 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $23.3 billion in Q1 2022 to a low of $18.5 billion in Q1 2026.
  • A 5-year average of $21.2 billion and a median of $21.2 billion in 2023 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets climbed 1.47% in 2023 and decreased 10.48% in 2026, its largest moves.
  • Tracing BHC's Non-Current Assets over 5 years: stood at $21.4 billion in 2022, then increased by 1.47% to $21.8 billion in 2023, then dropped by 4.62% to $20.7 billion in 2024, then fell by 2.6% to $20.2 billion in 2025, then fell by 8.36% to $18.5 billion in 2026.
  • Business Quant data shows BHC's Non-Current Assets at $18.5 billion in Q1 2026, $20.2 billion in Q4 2025, and $20.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn 18.52 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.52 Bn
Dec 31, 2025 20.21 Bn
Sep 30, 2025 20.58 Bn
Jun 30, 2025 20.75 Bn
Mar 31, 2025 20.69 Bn
Dec 31, 2024 20.75 Bn
Sep 30, 2024 21.19 Bn
Jun 30, 2024 21.28 Bn
Mar 31, 2024 21.52 Bn
Dec 31, 2023 21.75 Bn
Sep 30, 2023 22.02 Bn
Jun 30, 2023 21.04 Bn
Mar 31, 2023 21.21 Bn
Dec 31, 2022 21.44 Bn
Sep 30, 2022 22.29 Bn
Jun 30, 2022 22.75 Bn
Mar 31, 2022 23.25 Bn
Dec 31, 2021 23.60 Bn
Sep 30, 2021 23.93 Bn
Jun 30, 2021 24.59 Bn